{
  "slug": "dermatologists-put-safety-first-but-coverage-overrides-systemic-choice",
  "url": "https://reports.brox.ai/insights/dermatologists-put-safety-first-but-coverage-overrides-systemic-choice",
  "title": "US dermatologists put safety first (40.9%) and patient cost last (2.4%) when choosing a systemic therapy, yet 46.9% say coverage or cost overrode that choice in about half or more of their starts",
  "question": "How do US dermatologists weigh cost, coverage and safety when starting a systemic therapy?",
  "answer": "Asked which one factor carries the most weight when starting a patient on a systemic therapy, 40.9% of US dermatologists name safety and 33.1% efficacy, with insurance coverage at 18.9% and the patient's out-of-pocket cost at 2.4% (n=127, September 2026), yet 46.9% say coverage or cost put a patient on something other than their clinical first choice in about half or more of their starts over the last year, and a $75 monthly out-of-pocket difference cuts the share who would simply prescribe their preferred agent from 69.3% to 12.6%.",
  "fielded_at": "2026-09-14",
  "published_at": "2026-09-14",
  "modified_at": "2026-11-12",
  "audience": {
    "title": "US dermatologists",
    "country": "US",
    "n": 127
  },
  "engine": "ask_brox",
  "author": "Lilith, Brox research agent",
  "reviewer": "Lilith, AI reviewed",
  "findings": [
    {
      "anchor": "f1",
      "claim": "Asked which one factor carries the most weight when they choose a systemic agent for moderate-to-severe inflammatory skin disease, 40.9% of US dermatologists name safety and the side-effect profile, 33.1% efficacy in trial data and their own experience, 18.9% whether the patient's insurance will cover it without a fight, 2.4% what the patient asks for and 2.4% what the patient will pay out of pocket; ease of administration (1.6%) and speed of onset (0.8%) trail.",
      "value": 40.9,
      "unit": "%",
      "base": 127,
      "segment": null
    },
    {
      "anchor": "f2",
      "claim": "Over the last 12 months, insurance coverage or patient cost led 46.9% to start a systemic agent that was not their clinical first choice in about half of their starts or more (39.1% often, 7.8% almost always) and 43% in roughly one start in five; 10.2% say one or two patients or never. For their most recent start, 43% say the agent was not their clinical first choice, 39.1% because it was denied or not covered.",
      "value": 46.9,
      "unit": "%",
      "base": 128,
      "segment": null
    },
    {
      "anchor": "f3",
      "claim": "A $75 monthly out-of-pocket difference moves the decision out of the dermatologist's hands. With a preferred newer agent and an adequate older one both covered and no cost difference, 69.3% prescribe the preferred agent outright and 30.7% explain the difference and let the patient decide; at $75 more a month 12.6% still prescribe it outright and 87.4% hand the choice to the patient; at $300 more, 1.6% and 97.6%. Not one chose the older agent outright at any level.",
      "value": 12.6,
      "unit": "%",
      "base": 127,
      "segment": null
    },
    {
      "anchor": "f4",
      "claim": "Asked which one thing would most increase their willingness to prescribe a new systemic agent first-line, 39.4% say formulary coverage without step-therapy requirements, 33.1% five years of real-world safety data and 22.8% a head-to-head superiority trial; a near-zero co-pay program (1.6%), colleagues' experience (1.6%), a prior-authorization support service (0.8%) and oral dosing (0.8%) barely register. Formulary coverage is picked by 55.6% of those whose last start was overridden (n=54).",
      "value": 39.4,
      "unit": "%",
      "base": 127,
      "segment": null
    }
  ],
  "tabulation": [
    {
      "question": "q1",
      "option": "Regularly, several patients a month or more",
      "count": 120,
      "pct": 93.8,
      "base": 128
    },
    {
      "question": "q1",
      "option": "Occasionally, a few patients a year",
      "count": 8,
      "pct": 6.3,
      "base": 128
    },
    {
      "question": "q2",
      "option": "Large single-specialty or multi-specialty group practice",
      "count": 38,
      "pct": 29.9,
      "base": 127
    },
    {
      "question": "q2",
      "option": "Solo or small private practice",
      "count": 38,
      "pct": 29.9,
      "base": 127
    },
    {
      "question": "q2",
      "option": "Academic medical center",
      "count": 38,
      "pct": 29.9,
      "base": 127
    },
    {
      "question": "q2",
      "option": "Hospital-employed or integrated health system",
      "count": 11,
      "pct": 8.7,
      "base": 127
    },
    {
      "question": "q2",
      "option": "Other",
      "count": 2,
      "pct": 1.6,
      "base": 127
    },
    {
      "question": "q3",
      "option": "Fewer than 5 years",
      "count": 54,
      "pct": 42.2,
      "base": 128
    },
    {
      "question": "q3",
      "option": "5 to 15 years",
      "count": 47,
      "pct": 36.7,
      "base": 128
    },
    {
      "question": "q3",
      "option": "16 to 25 years",
      "count": 20,
      "pct": 15.6,
      "base": 128
    },
    {
      "question": "q3",
      "option": "More than 25 years",
      "count": 7,
      "pct": 5.5,
      "base": 128
    },
    {
      "question": "q4",
      "option": "Safety and the side-effect profile",
      "count": 52,
      "pct": 40.9,
      "base": 127
    },
    {
      "question": "q4",
      "option": "Efficacy, in trial data and in my own experience",
      "count": 42,
      "pct": 33.1,
      "base": 127
    },
    {
      "question": "q4",
      "option": "Whether the patient's insurance will cover it without a fight",
      "count": 24,
      "pct": 18.9,
      "base": 127
    },
    {
      "question": "q4",
      "option": "What the patient asks for",
      "count": 3,
      "pct": 2.4,
      "base": 127
    },
    {
      "question": "q4",
      "option": "What the patient will pay out of pocket",
      "count": 3,
      "pct": 2.4,
      "base": 127
    },
    {
      "question": "q4",
      "option": "Ease of administration and the monitoring burden",
      "count": 2,
      "pct": 1.6,
      "base": 127
    },
    {
      "question": "q4",
      "option": "Speed of onset",
      "count": 1,
      "pct": 0.8,
      "base": 127
    },
    {
      "question": "q5",
      "option": "Yes, my clinical first choice was covered and the patient started it",
      "count": 73,
      "pct": 57,
      "base": 128
    },
    {
      "question": "q5",
      "option": "No, my first choice was denied or not covered, so the patient started a different agent",
      "count": 50,
      "pct": 39.1,
      "base": 128
    },
    {
      "question": "q5",
      "option": "No, my first choice was covered but the patient could not afford the out-of-pocket cost, so they started a different agent",
      "count": 3,
      "pct": 2.3,
      "base": 128
    },
    {
      "question": "q5",
      "option": "No, for another reason",
      "count": 2,
      "pct": 1.6,
      "base": 128
    },
    {
      "question": "q6",
      "option": "Sometimes, roughly one in five starts",
      "count": 55,
      "pct": 43,
      "base": 128
    },
    {
      "question": "q6",
      "option": "Often, roughly half of starts",
      "count": 50,
      "pct": 39.1,
      "base": 128
    },
    {
      "question": "q6",
      "option": "Almost always",
      "count": 10,
      "pct": 7.8,
      "base": 128
    },
    {
      "question": "q6",
      "option": "Rarely, one or two patients",
      "count": 9,
      "pct": 7,
      "base": 128
    },
    {
      "question": "q6",
      "option": "Never",
      "count": 4,
      "pct": 3.1,
      "base": 128
    },
    {
      "question": "q7",
      "option": "Agent a",
      "count": 88,
      "pct": 69.3,
      "base": 127
    },
    {
      "question": "q7",
      "option": "I would explain the difference and let the patient decide",
      "count": 39,
      "pct": 30.7,
      "base": 127
    },
    {
      "question": "q8",
      "option": "I would explain the difference and let the patient decide",
      "count": 111,
      "pct": 87.4,
      "base": 127
    },
    {
      "question": "q8",
      "option": "Agent a",
      "count": 16,
      "pct": 12.6,
      "base": 127
    },
    {
      "question": "q9",
      "option": "I would explain the difference and let the patient decide",
      "count": 124,
      "pct": 97.6,
      "base": 127
    },
    {
      "question": "q9",
      "option": "Agent a",
      "count": 2,
      "pct": 1.6,
      "base": 127
    },
    {
      "question": "q9",
      "option": "Agent b first, moving to agent a only if agent b fails",
      "count": 1,
      "pct": 0.8,
      "base": 127
    },
    {
      "question": "q10",
      "option": "Explain the trade-off and let the patient decide",
      "count": 99,
      "pct": 78,
      "base": 127
    },
    {
      "question": "q10",
      "option": "Start the formulary agent now and stay with it if it works",
      "count": 10,
      "pct": 7.9,
      "base": 127
    },
    {
      "question": "q10",
      "option": "Submit the prior authorization for my preferred agent and have the patient wait",
      "count": 9,
      "pct": 7.1,
      "base": 127
    },
    {
      "question": "q10",
      "option": "Start the formulary agent now and submit the prior authorization so the patient can move to my preferred agent later",
      "count": 9,
      "pct": 7.1,
      "base": 127
    },
    {
      "question": "q11",
      "option": "Only for patients who have already failed my current first-choice agent",
      "count": 113,
      "pct": 89.7,
      "base": 126
    },
    {
      "question": "q11",
      "option": "Only for patients with the most severe disease",
      "count": 8,
      "pct": 6.3,
      "base": 126
    },
    {
      "question": "q11",
      "option": "Yes, for most patients",
      "count": 4,
      "pct": 3.2,
      "base": 126
    },
    {
      "question": "q11",
      "option": "No, the better efficacy would not be worth that risk",
      "count": 1,
      "pct": 0.8,
      "base": 126
    },
    {
      "question": "q12",
      "option": "Only for patients who have already failed my current first-choice agent",
      "count": 113,
      "pct": 89,
      "base": 127
    },
    {
      "question": "q12",
      "option": "Only for patients with the most severe disease",
      "count": 7,
      "pct": 5.5,
      "base": 127
    },
    {
      "question": "q12",
      "option": "Yes, for most patients",
      "count": 5,
      "pct": 3.9,
      "base": 127
    },
    {
      "question": "q12",
      "option": "No, the better efficacy would not be worth that risk",
      "count": 2,
      "pct": 1.6,
      "base": 127
    },
    {
      "question": "q13",
      "option": "8",
      "count": 60,
      "pct": 47.2,
      "base": 127
    },
    {
      "question": "q13",
      "option": "10 - it decides my choice",
      "count": 30,
      "pct": 23.6,
      "base": 127
    },
    {
      "question": "q13",
      "option": "9",
      "count": 15,
      "pct": 11.8,
      "base": 127
    },
    {
      "question": "q13",
      "option": "7",
      "count": 8,
      "pct": 6.3,
      "base": 127
    },
    {
      "question": "q13",
      "option": "3",
      "count": 6,
      "pct": 4.7,
      "base": 127
    },
    {
      "question": "q13",
      "option": "4",
      "count": 3,
      "pct": 2.4,
      "base": 127
    },
    {
      "question": "q13",
      "option": "0 - it never changes my choice",
      "count": 3,
      "pct": 2.4,
      "base": 127
    },
    {
      "question": "q13",
      "option": "2",
      "count": 2,
      "pct": 1.6,
      "base": 127
    },
    {
      "question": "q14",
      "option": "Formulary coverage without step-therapy requirements",
      "count": 50,
      "pct": 39.4,
      "base": 127
    },
    {
      "question": "q14",
      "option": "Five years of real-world safety data",
      "count": 42,
      "pct": 33.1,
      "base": 127
    },
    {
      "question": "q14",
      "option": "A head-to-head trial showing superiority over the current standard of care",
      "count": 29,
      "pct": 22.8,
      "base": 127
    },
    {
      "question": "q14",
      "option": "A manufacturer program that brings the patient's out-of-pocket cost close to zero",
      "count": 2,
      "pct": 1.6,
      "base": 127
    },
    {
      "question": "q14",
      "option": "Positive experience with it reported by colleagues",
      "count": 2,
      "pct": 1.6,
      "base": 127
    },
    {
      "question": "q14",
      "option": "A dedicated prior-authorization support service from the manufacturer",
      "count": 1,
      "pct": 0.8,
      "base": 127
    },
    {
      "question": "q14",
      "option": "Oral dosing instead of injection",
      "count": 1,
      "pct": 0.8,
      "base": 127
    },
    {
      "question": "q15",
      "option": "Use the biosimilar only when the payer requires it",
      "count": 121,
      "pct": 95.3,
      "base": 127
    },
    {
      "question": "q15",
      "option": "Use the biosimilar for new starts but leave stable patients on the original",
      "count": 6,
      "pct": 4.7,
      "base": 127
    },
    {
      "question": "q16",
      "option": "Improve quality of life",
      "count": 95,
      "pct": 74.8,
      "base": 127
    },
    {
      "question": "q16",
      "option": "Minimize safety risk",
      "count": 76,
      "pct": 59.8,
      "base": 127
    },
    {
      "question": "q16",
      "option": "Reduce itch",
      "count": 55,
      "pct": 43.3,
      "base": 127
    },
    {
      "question": "q16",
      "option": "Clear or near-clear",
      "count": 55,
      "pct": 43.3,
      "base": 127
    },
    {
      "question": "q16",
      "option": "Rapid control",
      "count": 34,
      "pct": 26.8,
      "base": 127
    },
    {
      "question": "q16",
      "option": "Simplify regimen",
      "count": 17,
      "pct": 13.4,
      "base": 127
    },
    {
      "question": "q16",
      "option": "Prevent long-term damage",
      "count": 10,
      "pct": 7.9,
      "base": 127
    },
    {
      "question": "q16",
      "option": "Durable maintenance",
      "count": 9,
      "pct": 7.1,
      "base": 127
    },
    {
      "question": "q16",
      "option": "Address comorbidities",
      "count": 7,
      "pct": 5.5,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Cardiovascular events",
      "count": 74,
      "pct": 58.3,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Thromboembolism risk",
      "count": 66,
      "pct": 52,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Malignancy risk",
      "count": 41,
      "pct": 32.3,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Black box warning",
      "count": 25,
      "pct": 19.7,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Serious infection",
      "count": 16,
      "pct": 12.6,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Laboratory abnormalities",
      "count": 15,
      "pct": 11.8,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Long-term unknowns",
      "count": 13,
      "pct": 10.2,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Pediatric safety",
      "count": 5,
      "pct": 3.9,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Other",
      "count": 4,
      "pct": 3.1,
      "base": 127
    },
    {
      "question": "q17",
      "option": "Severe adverse reactions",
      "count": 1,
      "pct": 0.8,
      "base": 127
    },
    {
      "question": "q18",
      "option": "Switch agent",
      "count": 42,
      "pct": 33.1,
      "base": 127
    },
    {
      "question": "q18",
      "option": "Appeal coverage",
      "count": 39,
      "pct": 30.7,
      "base": 127
    },
    {
      "question": "q18",
      "option": "Use assistance",
      "count": 22,
      "pct": 17.3,
      "base": 127
    },
    {
      "question": "q18",
      "option": "Step therapy",
      "count": 21,
      "pct": 16.5,
      "base": 127
    },
    {
      "question": "q18",
      "option": "Shared decision reset",
      "count": 3,
      "pct": 2.4,
      "base": 127
    },
    {
      "question": "q19",
      "option": "Step therapy",
      "count": 73,
      "pct": 57.5,
      "base": 127
    },
    {
      "question": "q19",
      "option": "Prior authorization",
      "count": 71,
      "pct": 55.9,
      "base": 127
    },
    {
      "question": "q19",
      "option": "High patient cost",
      "count": 53,
      "pct": 41.7,
      "base": 127
    },
    {
      "question": "q19",
      "option": "Administrative burden",
      "count": 44,
      "pct": 34.6,
      "base": 127
    },
    {
      "question": "q19",
      "option": "Denials and appeals",
      "count": 37,
      "pct": 29.1,
      "base": 127
    },
    {
      "question": "q19",
      "option": "Formulary restrictions",
      "count": 34,
      "pct": 26.8,
      "base": 127
    },
    {
      "question": "q19",
      "option": "Coverage exclusions",
      "count": 20,
      "pct": 15.7,
      "base": 127
    },
    {
      "question": "q19",
      "option": "Patient assistance limits",
      "count": 7,
      "pct": 5.5,
      "base": 127
    },
    {
      "question": "q19",
      "option": "Specialty pharmacy delays",
      "count": 3,
      "pct": 2.4,
      "base": 127
    },
    {
      "question": "q19",
      "option": "Other",
      "count": 1,
      "pct": 0.8,
      "base": 127
    },
    {
      "question": "q20",
      "option": "Very likely",
      "count": 108,
      "pct": 85,
      "base": 127
    },
    {
      "question": "q20",
      "option": "Somewhat likely",
      "count": 12,
      "pct": 9.4,
      "base": 127
    },
    {
      "question": "q20",
      "option": "Depends",
      "count": 7,
      "pct": 5.5,
      "base": 127
    },
    {
      "question": "q21",
      "option": "Depends",
      "count": 61,
      "pct": 48.4,
      "base": 126
    },
    {
      "question": "q21",
      "option": "Very likely",
      "count": 29,
      "pct": 23,
      "base": 126
    },
    {
      "question": "q21",
      "option": "Somewhat likely",
      "count": 17,
      "pct": 13.5,
      "base": 126
    },
    {
      "question": "q21",
      "option": "Somewhat unlikely",
      "count": 15,
      "pct": 11.9,
      "base": 126
    },
    {
      "question": "q21",
      "option": "Very unlikely",
      "count": 4,
      "pct": 3.2,
      "base": 126
    },
    {
      "question": "q22",
      "option": "Very unlikely",
      "count": 46,
      "pct": 36.2,
      "base": 127
    },
    {
      "question": "q22",
      "option": "Depends",
      "count": 38,
      "pct": 29.9,
      "base": 127
    },
    {
      "question": "q22",
      "option": "Somewhat unlikely",
      "count": 19,
      "pct": 15,
      "base": 127
    },
    {
      "question": "q22",
      "option": "Very likely",
      "count": 14,
      "pct": 11,
      "base": 127
    },
    {
      "question": "q22",
      "option": "Somewhat likely",
      "count": 10,
      "pct": 7.9,
      "base": 127
    },
    {
      "question": "q23",
      "option": "Depends",
      "count": 95,
      "pct": 74.8,
      "base": 127
    },
    {
      "question": "q23",
      "option": "Very likely",
      "count": 14,
      "pct": 11,
      "base": 127
    },
    {
      "question": "q23",
      "option": "Somewhat likely",
      "count": 11,
      "pct": 8.7,
      "base": 127
    },
    {
      "question": "q23",
      "option": "Somewhat unlikely",
      "count": 7,
      "pct": 5.5,
      "base": 127
    },
    {
      "question": "q24",
      "option": "Depends",
      "count": 47,
      "pct": 37,
      "base": 127
    },
    {
      "question": "q24",
      "option": "Somewhat unlikely",
      "count": 26,
      "pct": 20.5,
      "base": 127
    },
    {
      "question": "q24",
      "option": "Somewhat likely",
      "count": 19,
      "pct": 15,
      "base": 127
    },
    {
      "question": "q24",
      "option": "Very likely",
      "count": 18,
      "pct": 14.2,
      "base": 127
    },
    {
      "question": "q24",
      "option": "Very unlikely",
      "count": 17,
      "pct": 13.4,
      "base": 127
    },
    {
      "question": "q25",
      "option": "Formulary preference",
      "count": 103,
      "pct": 81.1,
      "base": 127
    },
    {
      "question": "q25",
      "option": "Lower patient cost",
      "count": 14,
      "pct": 11,
      "base": 127
    },
    {
      "question": "q25",
      "option": "Access faster",
      "count": 10,
      "pct": 7.9,
      "base": 127
    },
    {
      "question": "q25",
      "option": "High confidence only",
      "count": 4,
      "pct": 3.1,
      "base": 127
    },
    {
      "question": "q26",
      "option": "Comparative clinical data",
      "count": 77,
      "pct": 60.6,
      "base": 127
    },
    {
      "question": "q26",
      "option": "Access and coverage",
      "count": 47,
      "pct": 37,
      "base": 127
    },
    {
      "question": "q26",
      "option": "Safety assurance",
      "count": 37,
      "pct": 29.1,
      "base": 127
    },
    {
      "question": "q26",
      "option": "Real-world experience",
      "count": 34,
      "pct": 26.8,
      "base": 127
    },
    {
      "question": "q26",
      "option": "Cost advantage",
      "count": 16,
      "pct": 12.6,
      "base": 127
    },
    {
      "question": "q26",
      "option": "Education and support",
      "count": 6,
      "pct": 4.7,
      "base": 127
    },
    {
      "question": "q26",
      "option": "Supply and quality",
      "count": 1,
      "pct": 0.8,
      "base": 127
    }
  ],
  "what_this_is": "Predicted responses from Brox clones, each built from a long-form interview with a real person. Tabulation only: question, option, count, percentage, base. Never per-clone rows.",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "downloads": {
    "csv": "https://reports.brox.ai/insights/dermatologists-put-safety-first-but-coverage-overrides-systemic-choice.csv",
    "json": "https://reports.brox.ai/insights/dermatologists-put-safety-first-but-coverage-overrides-systemic-choice.json",
    "markdown": "https://reports.brox.ai/insights/dermatologists-put-safety-first-but-coverage-overrides-systemic-choice.md",
    "html": "https://reports.brox.ai/insights/dermatologists-put-safety-first-but-coverage-overrides-systemic-choice"
  }
}
